Expand AKTX Menu
AKTX MENU

AKTX Stock Summary and Trading Ideas (Akari Therapeutics PLC - American Depositary Shares | NASDAQ:AKTX)

Charts for Today's Stock Price and Implied Volatility in Akari Therapeutics PLC - American Depositary Shares

24-Jul-2024

Stock Price & Volume | Full Chart

Sentiment

Trading Statistics

Key Ratios

Akari Therapeutics PLC - American Depositary Shares (AKTX) Frequently Asked Questions

What does Akari Therapeutics PLC - American Depositary Shares do?

Akari Therapeutics PLC is a clinical stage biopharmaceutical company. It is focused on developing therapies for autoimmune and inflammatory diseases involving the complement component 5 (C5) and leukotriene B4 (LTB4) pathways. The company's pipelines include HSCT-TMA and Geographic Atrophy (GA).

What symbol and exchange does Akari Therapeutics PLC - American Depositary Shares stock trade?

Akari Therapeutics PLC - American Depositary Shares trades on the NASDAQ stock market under the symbol AKTX.

What is Akari Therapeutics PLC - American Depositary Shares stock price doing today?

As of July 24, 2024, AKTX stock price declined to $3.91 with 20,711 million shares trading.

What is Akari Therapeutics PLC - American Depositary Shares's Beta?

AKTX has a beta of 1.44, meaning it tends to be more sensitive to market movements. AKTX has a correlation of 0.03 to the broad based SPY ETF.

How much is Akari Therapeutics PLC - American Depositary Shares worth?

AKTX has a market cap of $45.91 million. This is considered a Sub-Micro Cap stock.

What is the highest and lowest price Akari Therapeutics PLC - American Depositary Shares traded in the last 3 year period?

In the last 3 years, AKTX stock traded as high as $37.60 and as low as $1.08.

Is Akari Therapeutics PLC - American Depositary Shares (AKTX) a good investment?

AKTX stock has underperformed the market in the last year with a return of +12.1%, while SPY returned +20.7%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in AKTX shares. However, AKTX has outperformed the market in the last 3 month and 2 week periods, returning +228.6% and +15.7%, while SPY returned +7.4% and -2.6%, respectively. This indicates AKTX has been having a stronger performance recently.

What is the support and resistance for Akari Therapeutics PLC - American Depositary Shares (AKTX) stock price?

AKTX support price is $3.70 and resistance is $4.43 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that AKTX stock will trade within this expected range on the day.